🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to implement two interventions to determine the most effect...
Status
Not Yet Recruiting
Location
Danfa Community
Start Date
2026-10-01
Trial ID
NCT07745517
This study will explore the efficacy and safety of tislelizumab (PD1 inhibi...
Status
Unknown
Location
Multiple Locations
Start Date
2022-06-20
Trial ID
NCT05350917
Treatments Being Tested
This study aims to evaluate the effects of a combined dietary-nutritional a...
Status
Active Not Recruiting
Location
European Institute Of Exercise and Health
Start Date
2023-09-01
Trial ID
NCT07275957
Brief Summary The goal of this observational study is to learn about patie...
Status
Completed
Location
Marmara University Faculty of Dentistry
Start Date
2023-06-02
Trial ID
NCT07174271
Lifestyle interventions combining nutrition, physical activity, and behavio...
Status
Completed
Location
New York University Abu Dhabi
Start Date
2024-09-16
Trial ID
NCT07662499
Treatments Being Tested
The JITAI approach holds considerable promise for addressing current challe...
Status
Not Yet Recruiting
Location
The Chinese University of Hong Kong
Start Date
2026-01-01
Trial ID
NCT07277049
Treatments Being Tested
This study will evaluate the ability of a largely self-administered geriatr...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Basking Ridge
Start Date
2013-04
Trial ID
NCT01829958
Treatments Being Tested
This Split-mouth randomized clinical trial aims to evaluate CAD/CAM prefabr...
Status
Active Not Recruiting
Location
School of Dental Medicine
Start Date
2024-04-02
Trial ID
NCT07618871
This randomized controlled trial (RCT) aims to evaluate the effectiveness o...
Status
Recruiting
Location
Faculty of Physical Therapy, Al Hayah University
Start Date
2025-04-22
Trial ID
NCT06916663
Nuedexta is FDA approved for the treatment of pseudobulbar affect in ALS pa...
Status
Completed
Location
Phil Smith Neuroscience Institute at Holy Cross Hospital
Start Date
2019-07-25
Trial ID
NCT03883581
Treatments Being Tested